This article covers a symposium that took place on 10th September 2022 as part of the European Society for Medical Oncology (ESMO) annual congress held in Paris, France, from 9th–13th September 2022. Experts provided an overview of cholangiocarcinoma (CCA), including the diagnostic challenges and treatment options for patients with CCA, as well as the importance of molecular profiling and the multidisciplinary team for the management of these patients.
To watch the full symposium click here
